Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Orchestra BioMed Holdings Inc., 3 years.
Orchestra BioMed Holdings Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −5,145 | $4.42 | $22,741 |
| Jun 24, 2026 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −4,261 | — | — |
| Jun 23, 2026 | Orchestra BioMed Holdings Inc. | Grant or award | +17,327 | — | — |
| May 14, 2026 | Orchestra BioMed Holdings Inc. | Open-market purchase | +20,000 | $4.13 | $82,600 |
| Aug 25, 2025 | Orchestra BioMed Holdings Inc. | Open-market purchase | +5,760 | $2.61 | $15,034 |
| Aug 7, 2025 | Orchestra BioMed Holdings Inc. | Grant or award | +7,500 | — | — |
| Aug 7, 2025 | Orchestra BioMed Holdings Inc. | Grant or award | +7,500 | — | — |
| Jun 26, 2025 | Orchestra BioMed Holdings Inc. | Open-market sale | −2,683 | $3.05 | $8,183 |
| Jun 24, 2025 | Orchestra BioMed Holdings Inc. | Grant or award | +12,422 | — | — |
| Sep 10, 2024 | Orchestra BioMed Holdings Inc. | Open-market sale | −1,800 | $5.34 | $9,612 |
| Sep 9, 2024 | Orchestra BioMed Holdings Inc. | Open-market sale | −1,800 | $5.43 | $9,774 |
| Sep 6, 2024 | Orchestra BioMed Holdings Inc. | Open-market sale | −2,000 | $5.64 | $11,280 |
| Jun 20, 2024 | Orchestra BioMed Holdings Inc. | Grant or award | +5,376 | — | — |
| Jul 20, 2023 | Orchestra BioMed Holdings Inc. | Grant or award | +11,667 | — | — |
| May 10, 2023 | Orchestra BioMed Holdings Inc. | Option exercise | +2,906 | $1.08 | $3,138 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.